StonvexLoading…
StonvexCore line items from REXR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $589.00K | $611.00K | $682.00K | $616.00K |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $212.03M | $273.80M | $238.02M | $167.58M |
EPS (Diluted) | $0.86 | $1.20 | $1.12 | $0.92 |
Total Assets | $12.61B | $12.65B | $10.93B | $9.26B |
Total Liabilities | $3.77B | $3.92B | $2.79B | $2.34B |
Cash & Equivalents | $165.78M | $55.97M | $33.44M | $36.79M |
Free Cash Flow OCF − CapEx | $208.66M | $105.53M | $160.98M | $192.60M |
Shares Outstanding | 231.58M | 225.29M | 212.35M | 189.11M |